P.E. ASIA BIOMEDICINE CO., LTD.
Update：2026/11/10
Industries
Main Industry
Consumer Goods
Main Product/Service
Skin-Activating Complex Factor Skincare
The content above was translated by Ai
Founded Year
2012
Unified Business No.
53931215
Status
Active
Number of Employees
15
Total Paid-in
Capital
29,900,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
P.E. ASIA BIOMEDICINE CO., LTD. is an innovative growth group focused on independent research and development, mastering core technologies, and developing high-quality products. In 2002, the research and development team collaborated with a team of plastic surgeons and Chia Nan University of Pharmacy and Science to begin research and development on the application of stem cells and the development of biotech skincare beauty products. After ten years of refinement, the company now owns skincare factories in Taiwan, Shanghai, and the United States, as well as a biotechnology laboratory in the United States. It has also applied for industry-academia collaboration projects of the National Science Council, successfully developing stem cell liposomal encapsulation technology. Today, its ultimate goal is to create a beautiful life. By combining industry, government, academia, and clinical practical experience, the company has created Asia's first "2025 Future Series" skincare products. Adhering to the business principles of "leading brand, high-quality products, satisfactory customer service, and sharing beauty," it specializes in cosmetics research and development, guiding and sharing with product enthusiasts on their journey toward a beautiful life.
The content above was translated by Ai
